IRIS Accounts Production v24.3.2.46 SC629882 director 1.6.23 31.5.24 31.5.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC6298822023-05-31SC6298822024-05-31SC6298822023-06-012024-05-31SC6298822022-05-31SC6298822022-06-012023-05-31SC6298822023-05-31SC629882ns15:Scotland2023-06-012024-05-31SC629882ns14:PoundSterling2023-06-012024-05-31SC629882ns10:Director12023-06-012024-05-31SC629882ns10:PrivateLimitedCompanyLtd2023-06-012024-05-31SC629882ns10:SmallEntities2023-06-012024-05-31SC629882ns10:AuditExemptWithAccountantsReport2023-06-012024-05-31SC629882ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-31SC629882ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-31SC629882ns10:FullAccounts2023-06-012024-05-31SC629882ns10:RegisteredOffice2023-06-012024-05-31SC629882ns5:CurrentFinancialInstruments2024-05-31SC629882ns5:CurrentFinancialInstruments2023-05-31SC629882ns5:Non-currentFinancialInstruments2024-05-31SC629882ns5:Non-currentFinancialInstruments2023-05-31SC629882ns5:ShareCapital2024-05-31SC629882ns5:ShareCapital2023-05-31SC629882ns5:RetainedEarningsAccumulatedLosses2024-05-31SC629882ns5:RetainedEarningsAccumulatedLosses2023-05-31SC629882ns5:LeaseholdImprovements2023-05-31SC629882ns5:PlantMachinery2023-05-31SC629882ns5:ComputerEquipment2023-05-31SC629882ns5:LeaseholdImprovements2023-06-012024-05-31SC629882ns5:PlantMachinery2023-06-012024-05-31SC629882ns5:ComputerEquipment2023-06-012024-05-31SC629882ns5:LeaseholdImprovements2024-05-31SC629882ns5:PlantMachinery2024-05-31SC629882ns5:ComputerEquipment2024-05-31SC629882ns5:LeaseholdImprovements2023-05-31SC629882ns5:PlantMachinery2023-05-31SC629882ns5:ComputerEquipment2023-05-31SC629882ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-31SC629882ns5:WithinOneYearns5:CurrentFinancialInstruments2023-05-31
REGISTERED NUMBER: SC629882 (Scotland)















Financial Statements

for the Year Ended

31st May 2024

for

CBD Infusions (Scotland) Ltd

CBD Infusions (Scotland) Ltd (Registered number: SC629882)






Contents of the Financial Statements
for the Year Ended 31st May 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Certified Accountants' Report 6

CBD Infusions (Scotland) Ltd

Company Information
for the Year Ended 31st May 2024







DIRECTOR: I A Thomson





REGISTERED OFFICE: 58 Long Lane
Broughty Ferry
Dundee
DD5 1HH





REGISTERED NUMBER: SC629882 (Scotland)





ACCOUNTANTS: AWH
Chartered Certified Accountants
Fort Street House
63 Fort Street
Broughty Ferry
Dundee
Angus
DD5 2AB

CBD Infusions (Scotland) Ltd (Registered number: SC629882)

Balance Sheet
31st May 2024

31.5.24 31.5.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,291 1,508

CURRENT ASSETS
Stocks 33,276 38,400
Debtors 5 2,500 2,673
Cash at bank and in hand 1,726 2,216
37,502 43,289
CREDITORS
Amounts falling due within one year 6 57,855 23,290
NET CURRENT (LIABILITIES)/ASSETS (20,353 ) 19,999
TOTAL ASSETS LESS CURRENT
LIABILITIES

(18,062

)

21,507

CREDITORS
Amounts falling due after more than one
year

7

7,500

10,500
NET (LIABILITIES)/ASSETS (25,562 ) 11,007

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (25,563 ) 11,006
SHAREHOLDERS' FUNDS (25,562 ) 11,007

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st May 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CBD Infusions (Scotland) Ltd (Registered number: SC629882)

Balance Sheet - continued
31st May 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11th February 2025 and were signed by:





I A Thomson - Director


CBD Infusions (Scotland) Ltd (Registered number: SC629882)

Notes to the Financial Statements
for the Year Ended 31st May 2024

1. STATUTORY INFORMATION

CBD Infusions (Scotland) Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 3 ) .

CBD Infusions (Scotland) Ltd (Registered number: SC629882)

Notes to the Financial Statements - continued
for the Year Ended 31st May 2024

4. TANGIBLE FIXED ASSETS
Improvements
to Plant and Computer
property machinery equipment Totals
£    £    £    £   
COST
At 1st June 2023 - 2,662 3,117 5,779
Additions 1,424 - 313 1,737
At 31st May 2024 1,424 2,662 3,430 7,516
DEPRECIATION
At 1st June 2023 - 1,571 2,700 4,271
Charge for year 214 219 521 954
At 31st May 2024 214 1,790 3,221 5,225
NET BOOK VALUE
At 31st May 2024 1,210 872 209 2,291
At 31st May 2023 - 1,091 417 1,508

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Other debtors 2,500 2,673

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Trade creditors 72 20
Taxation and social security 576 314
Other creditors 57,207 22,956
57,855 23,290

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.5.24 31.5.23
£    £   
Bank loans 7,500 10,500

Chartered Certified Accountants' Report to the Director
on the Unaudited Financial Statements of
CBD Infusions (Scotland) Ltd

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of CBD Infusions (Scotland) Ltd for the year ended 31st May 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the director of CBD Infusions (Scotland) Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of CBD Infusions (Scotland) Ltd and state those matters that we have agreed to state to the director of CBD Infusions (Scotland) Ltd in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at
https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that CBD Infusions (Scotland) Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of CBD Infusions (Scotland) Ltd. You consider that CBD Infusions (Scotland) Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of CBD Infusions (Scotland) Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






AWH
Chartered Certified Accountants
Fort Street House
63 Fort Street
Broughty Ferry
Dundee
Angus
DD5 2AB


11th February 2025